WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000027340) USE OF t-RNA AND FRAGMENTS FOR INHIBITING ANGIOGENESIS AND COMPOSITIONS THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/027340    International Application No.:    PCT/US1999/026696
Publication Date: 18.05.2000 International Filing Date: 12.11.1999
Chapter 2 Demand Filed:    07.06.2000    
IPC:
A61K 38/00 (2006.01), C12N 15/11 (2006.01)
Applicants: THE CHILDREN'S MEDICAL CENTER CORPORATION [US/US]; 300 Longwood Avenue Boston, MA 02225 (US) (For All Designated States Except US).
SHING, Yuen [US/US]; (US) (For US Only).
ZHAO, Hui [CN/US]; (US) (For US Only).
BOJANOWSKI, Krzystof [PL/US]; (US) (For US Only).
FOLKMAN, M., Judah [US/US]; (US) (For US Only)
Inventors: SHING, Yuen; (US).
ZHAO, Hui; (US).
BOJANOWSKI, Krzystof; (US).
FOLKMAN, M., Judah; (US)
Agent: WARREN, William, L.; Jones & Askew, LLP 2400 Monarch Tower 3424 Peachtree Road, N.E. Atlanta, GA 30326 (US)
Priority Data:
60/108,036 12.11.1998 US
Title (EN) USE OF t-RNA AND FRAGMENTS FOR INHIBITING ANGIOGENESIS AND COMPOSITIONS THEREOF
(FR) COMPOSITIONS ET METHODES D'INHIBITION DE L'ANGIOGENESE AVEC UN ARN DE TRANSFERT ET SES FRAGMENTS
Abstract: front page image
(EN)A therapeutic composition comprising an angiogenesis-inhibiting amount of a transfer ribonucleic acid (tRNA) or a fragment of tRNA and a pharmaceutically acceptable excipient are provided. Methods of administering the composition to inhibit an angiogenesis-dependent disease, such as cancer, are also provided.
(FR)La présente invention concerne une composition thérapeutique comprenant une dose inhibitant l'angiogenèse d'un acide ribonucléïque de transfert (ARNt) ou d'un fragment d'ARNt et un excipient pharmaceutiquement acceptable. Des méthodes d'administration de la composition pour inhiber une maladie liée à l'angiogenèse, telle que le cancer, sont également présentées.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)